News - Respiratory and Pulmonary, Gastro-intestinals

Filter

Popular Filters

Forest Laboratories announces new appointments to its executive team

16-12-2013

New York-based pharmaceutical company Forest Laboratories (NYSE: FRX) has announced new appointments…

Anti-viralsBoardroomCardio-vascularCNS DiseasesForest LaboratoriesGastro-intestinalsPharmaceuticalRespiratory and PulmonaryUSA

GA and PhRMA partner on pilot scheme to enhance patient engagement in three therapy areas

05-11-2013

The USA’s Genetic Alliance and the Pharmaceutical Research and Manufacturers of America have announced…

Gastro-intestinalsHealthcareHematologyNorth AmericaPharmaceuticalRespiratory and Pulmonary

Abraaj sells stake in Opalia Pharma to Recordati

05-11-2013

The Dubai-based Abraaj Group, an investor operating in global growth markets, has announced its full…

Abraaj GroupDermatologicalsGastro-intestinalsGenericsMergers & AcquisitionsOpalia PharmaRecordatiRespiratory and PulmonaryRest of the World

Salix and Alfa Wassermann expand rifaximin accord

10-08-2012

USA-based Salix Pharmaceuticals (Nasdaq: SLXP) and Italy's Alfa Wassermann have entered into an exclusive…

Alfa WassermannGastro-intestinalsLicensingPharmaceuticalRespiratory and PulmonaryrifaximinSalix Pharmaceuticals

Paladin gets certain rights to Immuron’s Travelan in up to C$117 million deal

30-11-2011

Melbourne, Australia-based Immuron (ASX: IMC) and Canada’s Paladin Labs (TSX: PLB) have signed a…

Gastro-intestinalsImmuronLicensingPaladin LabsPharmaceuticalRespiratory and PulmonaryTravelan

Anti-inflammatory therapeutics market to grow to $85.9 billion in 2017

06-11-2011

The anti-inflammatory therapeutics market accounted for $32.3 billion in 2002 from its seven major indications.…

Anti-Arthritics/RheumaticsGastro-intestinalsMarkets & MarketingNeurologicalPharmaceuticalRespiratory and Pulmonary

Nycomed to market Almirall’s Kestine in Southeast Asia markets; files for linaclotide in EU

30-09-2011

Swiss drug maker Nycomed, currently the subject of a 9.6 billion-euro takeover by Japan’s Takeda…

AlmirallAsia-PacificEuropeGastro-intestinalsLicensinglinaclotideNycomedPharmaceuticalRegulationRespiratory and Pulmonary

Back to top